The performance of the Capilia TB-Neo assay, a new-generation assay, was assessed by determining its sensitivity, specificity, reproducibility, and cross-reaction with contaminating organisms. The sensitivity and specificity were 99.2 and 96.4% and 89.3 and 100% in pure and mixed-culture isolates, respectively. The kappa statistic was 95.0 and 77.9% in pure and mixed culture isolates, respectively. There was no cross-reaction with contaminating organisms.
T
he Capilia TB assay is a rapid, simple, and inexpensive identification test for identification of mycobacterial culture isolates that has been evaluated extensively (1) (2) (3) (4) (5) (6) (7) . A new generation of this assay, the Capilia TB-Neo assay (Capilia), has been developed, replacing the original assay (Y. Namba, 8 September 2010, European patent application EP 2226635 A1). The original assay has been shown to have sensitivity and specificity ranging from 92% to 100% (1, 2, 6) . Cross-reaction with other mycobacteria and other bacteria has been demonstrated with the original assay (1, 7; Y. Namba, 8 September 2010, European patent application EP 2226635 A1). As a result, a new assay was developed to replace the original assay to take care of the cross-reaction and to improve the specificity (Y. Namba, 8 September 2010, European patent application EP 2226635 A1). So far, there are only two published studies that have evaluated this next-generation assay, and the studies show conflicting results. An overall reduction in sensitivity and specificity was observed by Gomathi et al. (8)-76% and 86%, respectively. However, Pokam et al. reported a sensitivity and specificity approaching 100%, comparable to those of the original assay (9) .
The study was conducted on isolates from an ongoing study that is evaluating the use of the GeneXpert MTB/RIF test (Xpert) in Lusaka, Zambia. Sputum samples were collected from suspected tuberculosis (TB) and confirmed TB patients attending routine services for whom Xpert detected TB or TB with rifampin resistance and from 10% of those for whom Xpert did not detect TB, for quality assurance, confirmation of rifampin resistance, and treatment monitoring purposes. The study had ethical approval from the University of Zambia Ethics Committee, and all patients provided written informed consent before submitting sputum samples for mycobacterial culture.
Sputum specimens were decontaminated using the N-acetyl-L-cysteine (NALC)-NaOH method and were inoculated in a manual mycobacterial growth indicator tube (MGIT; BD) according to standard operating procedures (10, 11) . All growth-positive tubes were subjected to Ziehl-Neelsen (ZN) staining, and the Capilia test was performed on all culture isolates confirmed to contain acid-fast bacilli (AFB). Capilia test-negative isolates were confirmed using the GenoType Mycobacterium Common Mycobacteria (GTM_CM) test (Hain Lifescience, Nehren, Germany). Further, isolates from patients with Mycobacterium tuberculosis/ Xpert-detected rifampin resistance were confirmed using the MTBDRplus assay as part of protocols for the primary study. The results of the GTM_CM and MTBDRplus assays (line probe assays [LPA]) were combined to create a gold standard for determining the sensitivity and specificity of the Capilia assay. The MGIT tubes containing the culture isolates were stored at 4°C for a median time of 122 (interquartile range [IQR], 102 to 146) days, and a random selection of these was later retested with the Capilia assay to determine reproducibility.
Cross-reaction with contaminating organisms was assessed by conducting the Capilia test on a random selection of 55 cultures classified as contaminated (AFB negative/contaminant seen). All testing was blinded. Using the kappa statistic, the overall reproducibility and the reproducibility for pure cultures and for mixed cultures were also determined separately. To measure reproducibility, fully positive and faintly positive isolates were combined and considered a positive result. Isolates that were Capilia test positive but gold standard negative were subjected to further testing to confirm the absence or presence of Mycobacterium tuberculosis using the Xpert assay. The broth was vortexed, 0.5 to 1 ml was aliquoted into a Falcon tube, and 1.5 to 3 ml of lysate was added to have a 1-in-3 dilution. The broth mix was incubated for a maximum of 15 min with intermittent vortexing. Two milliliters of the lysed broth mix was added to the cartridge and loaded into the Xpert instrument. All tests included positive and negative controls.
The overall sensitivity of the Capilia TB-Neo assay was 97.4%, and the specificity was 99.1%. For pure isolates, the sensitivity was 99.2% and specificity was 96.4%, while for mixed isolates, the sensitivity and specificity were 89.3% and 100%, respectively (Tables 1 and 2).
The overall kappa was 87.7%, while for pure isolates only, it was 95.0%, and on mixed isolates, it was 77.9% (Table 3) .
Among 52 samples that were Capilia test negative the first time, 1 converted to positive and 3 converted to faintly positive on repeat testing.
The Capilia TB-Neo assay was negative on 52/55(94.5%) contaminated cultures, positive on 2 cultures, and faintly positive on 1 culture. The isolates that were Capilia test positive were confirmed to be M. tuberculosis by LPA, while the isolate that was Capilia test faintly positive contained high-GC Gram-positive bacteria but was Xpert MTB/RIF test positive.
The overall sensitivity and specificity of 97.4% and 99.1%, respectively, found in this study are higher than those reported by Gomanthi et al. but similar to those reported by Pokam et al. (8, 9) . In our study, the Capilia TB-Neo assay had a lower sensitivity when performed on mixed cultures than when performed on pure cultures (89.3% versus 99.2%), confirming the findings by Gomanthi et al. (8) but contradicting findings by Muchwa et al., who found that the Capilia assay sensitivities were similar for both pure and mixed culture isolates, though this study did not state which generation of the Capilia TB assay they evaluated (12) .
The Capilia TB-Neo test showed false-negative results on 4 isolates that were identified as M. tuberculosis by LPA. Upon repeating the assay, two converted to Capilia faintly positive while one isolate maintained the negative result and one did not have repeat Capilia results. The isolate that maintained the negative Capilia assay result on repeated testing could be due to mutation on the MPB64 gene that results in nonproduction of the MPB64 antigen, resulting in a false-negative Capilia assay result (2, 4). The two isolates that converted from negative to faintly positive suggest that initially the isolates did not contain enough CFU (1) to meet the threshold for the Capilia assay to detect the MPB64 antigen. This finding suggests that prolonged incubation for Capilia test-negative isolates may be required as recommended by Gomanthi et al., who also had similar findings (8) .
The reproducibility of the Capilia TB-Neo assay was almost perfect on pure isolates ( ϭ 0.95), while on mixed isolates, it was slightly lower ( ϭ 0.78), an indication that the performance of this assay is negatively affected when used on isolates containing contaminants. This may pose a problem in settings such as ours where contamination on MGIT cultures is generally high (8, 13, 14) and may thus require that mixed cultures are further confirmed with another test, but this would result in higher costs and defeat the advantage that the Capilia assay can be performed on mixed isolates, unlike biochemical tests.
Cross-reaction was not observed in this study, but we noted a failure by our gold standard to detect M. tuberculosis in Capilia test-positive isolates that also contained contaminating bacteria (mixed cultures). The gold standard on repeated testing failed to detect TB in these isolates, but Xpert detected M. tuberculosis. With these findings, careful interpretation of results is required, taking into consideration the gold standard that is used especially where contamination is high.
The three contaminated isolates that were found to be M. tuberculosis by both Capilia assay and LPA suggest that AFB were missed during ZN stain slide reading, and this is most likely to occur in cultures with low CFU and heavy contamination with other organisms, as was the case with these cultures.
Conclusions. In this evaluation, we have confirmed that the new generation of the Capilia assay is highly sensitive, specific, and reproducible and that performance of the test is negatively affected when culture isolates are mixed with contaminating bacteria. No cross-reaction with other contaminating bacteria was observed in this study, and the limitations of the gold standard used should be considered when interpreting results. The performance of the GTM_CM was also negatively affected in M. tuberculosis isolates with a heavy presence of contaminating bacteria.
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